Fate Therapeutics (FATE) Prepaid Assets (2012 - 2026)
Fate Therapeutics' (FATE) quarterly Prepaid Assets came in at $4.0 million in Q1 2026, down 25.73% YoY from $5.4 million in Q1 2025, and down 3.17% on a QoQ basis from $4.1 million in Q4 2025.
Fate Therapeutics (FATE) Prepaid Assets (2012 - 2026) Analysis & Trends
Fate Therapeutics (FATE) has 15 years of Prepaid Assets data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 25.73% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 25.73% YoY) and the FY2025 annual result came in at $4.1 million, down 55.59% from the prior year.
- Prepaid Assets retreated to $4.0 million in Q1 2026, from $4.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $27.4 million in Q4 2022 to a low of $4.0 million in Q1 2026.
- A 5-year average of $11.6 million and a median of $11.4 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 210.07% — and 2025, when it tumbled 55.59%.
- Tracing FATE's Prepaid Assets over 5 years: stood at $27.4 million in 2022, then slumped by 46.87% to $14.5 million in 2023, then sank by 36.02% to $9.3 million in 2024, then plunged by 55.59% to $4.1 million in 2025, then retreated by 3.17% to $4.0 million in 2026.
- The last three Prepaid Assets figures came in at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.13 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 9.30 Mn |
| Sep 30, 2024 | 9.24 Mn |
| Jun 30, 2024 | 13.46 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 14.54 Mn |
| Sep 30, 2023 | 12.90 Mn |
| Jun 30, 2023 | 11.41 Mn |
| Mar 31, 2023 | 15.49 Mn |
| Dec 31, 2022 | 27.37 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 17.18 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 8.83 Mn |
| Sep 30, 2021 | 7.70 Mn |
| Jun 30, 2021 | 7.37 Mn |